Electrical and Pharmacologic Cardioversion for Atrial Fibrillation

Cardiology Clinics

Volumn 27, Issue 1, 2009, Pages 95-107

  Kim, Susan S ^a   Knight, Bradley P ^a  

^a UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

Atrial fibrillation; Cardioversion; Electrical

Indexed keywords

AMIODARONE; IBUTILIDE; VERAPAMIL;

CARDIOVASCULAR RISK; CARDIOVERSION; ELECTROCARDIOGRAM; HEART ATRIUM CONTRACTION; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HEART CATHETERIZATION; HEART FAILURE; HUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REVIEW; SINUS RHYTHM;

ANTI-ARRHYTHMIA AGENTS; ANTICOAGULANTS; ATRIAL FIBRILLATION; DEFIBRILLATORS; ELECTRIC COUNTERSHOCK; EQUIPMENT DESIGN; HEART CATHETERIZATION; HEART RATE; HUMANS; THROMBOEMBOLISM; TREATMENT OUTCOME;

EID: 57949112683     PISSN: 07338651     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccl.2008.09.008     Document Type: Review

References (61)

1. Fuster V., Ryden L.E., Cannom D.S., et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 guidelines for the management of patients with atrial fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 114 7 (2006) E257-E354
2. Wijffels M.C.E.F., Kirchhof C.J.H.J., Dorland R., et al. Atrial fibrillation begets atrial fibrillation. Circulation 92 (1995) 1954-1968
3. Kopecky S.L., Gersh B.J., McGoon M.D., et al. The natural history of lone atrial fibrillation: a population based study over three decades. N Engl J Med 317 (1987) 669-674
4. Godtfredsen J. Atrial fibrillation: etiology, course and prognosis: a follow-up study of 1212 cases (1975), Munksgaard, Copenhagen (Denmark)
5. Van Gelder I.C., Crijns H.J., Van Gilst W.H., et al. Prediction of uneventful cardioversion and maintenance of sinus rhythm from direct-current electrical cardioversion of chronic atrial fibrillation and flutter. Am J Cardiol 68 1 (1991) 41-46
6. The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 347 (2002) 1825-1833
7. Van Gelder I.C., Hagens V.E., Bosker H.A., et al., Rate Control versus Electrical Cardioversion for Persistent Atrial Fibrillation Study Group. A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N Engl J Med 347 23 (2002) 1834-1840
8. Alegret J.M., Viñolas X., Sagristá J., et al., REVERSE Study Investigators. Predictors of success and effect of biphasic energy on electrical cardioversion in patients with persistent atrial fibrillation. Europace 9 10 (2007) 942-946
9. Boriani G., Diemberger I., Biffi M., et al. Electrical cardioversion for persistent atrial fibrillation or atrial flutter in clinical practice: predictors of long-term outcome. Int J Clin Pract 61 5 (2007) 748-756
10. Dudley Jr. S.C., Hoch N.E., McCann L.A., et al. Atrial fibrillation increases production of superoxide by the left atrium and left atrial appendage: role of the NADPH and xanthine oxidases. Circulation 112 9 (2005) 1266-1273
11. O'Neill P.G., Puleo P.R., Bolli R., et al. Return of atrial mechanical function following electrical conversion of atrial dysrhythmias. Am Heart J 120 2 (1990) 353-359
12. Laupacis A., Albers G., Dalen J., et al. Antithrombotic therapy in atrial fibrillation. Chest 114 5 Suppl (1998) 579S-589S
13. Manning W.J., Leeman D.E., Gotch P.J., et al. Pulsed Doppler evaluation of atrial mechanical function after electrical cardioversion of atrial fibrillation. J Am Coll Cardiol 13 3 (1989) 617-623
14. Bjerkelund C., and Orning O. The efficacy of anticoagulant therapy in preventing embolism related to DC electrical conversion of atrial fibrillation. Am J Cardiol 23 (1969) 208-216
15. Stellbrink C., Nixdorff U., Hofmann T., et al., ACE (Anticoagulation in Cardioversion using Enoxaparin) Study Group. Safety and efficacy of enoxaparin compared with unfractionated heparin and oral anticoagulants for prevention of thromboembolic complications in cardioversion of nonvalvular atrial fibrillation: the Anticoagulation in Cardioversion using Enoxaparin (ACE) trial. Circulation 109 8 (2004) 997-1003
16. Gallagher M.M., Hennessy B.J., Edvardsson N., et al. Embolic complications of direct current cardioversion of atrial arrhythmias: association with low intensity of anticoagulation at the time of cardioversion. J Am Coll Cardiol 40 5 (2002) 926-933
17. Klein A.L., Grimm R.A., Murray R.D., et al., Assessment of Cardioversion Using Transesophageal Echocardiography Investigators. Use of transesophageal echocardiography to guide cardioversion in patients with atrial fibrillation. N Engl J Med 344 19 (2001) 1411-1420
18. Berger M., and Schweitzer P. Timing of thromboembolic events after electrical cardioversion of atrial fibrillation or flutter: a retrospective analysis. Am J Cardiol 82 12 (1998) 1545-1547 A8. Full-Text PDF (62 KB)
19. Weigner M.J., Caulfield T.A., Danias P.G., et al. Risk for clinical thromboembolism associated with conversion to sinus rhythm in patients with atrial fibrillation lasting less than 48 hours. Ann Intern Med 126 8 (1997) 615-620
20. Strickberger S.A., Ip J., Saksena S., et al. Relationship between atrial tachyarrhythmias and symptoms. Heart Rhythm 2 2 (2005) 125-131
21. Mittal S., Ayati S., Stein K.M., et al. Transthoracic cardioversion of atrial fibrillation: comparison of rectilinear biphasic versus damped sine wave monophasic shocks. Circulation 101 11 (2000) 1282-1287
22. Zhou X., Daubert J.P., Wolf P.D., et al. Epicardial mapping of ventricular defibrillation with monophasic and biphasic shocks in dogs. Circ Res 72 1 (1993) 145-160
23. Dahl C.F., Ewy G.A., Warner E.D., et al. Myocardial necrosis from direct current countershock: effect of paddle electrode size and time interval between discharges. Circulation 50 (1974) 956-961
24. Joglar J.A., Kessler D.J., Welch P.J., et al. Effects of repeated electrical defibrillations on cardiac troponin I levels. Am J Cardiol 83 (1999) 270-272
25. Lown B., Perlroth M.G., Kaidbey S., et al. "Cardioversion" of atrial fibrillation. A report on the treatment of 65 episodes in 50 patients. N Engl J Med 269 (1963) 325-331
26. Mittal S., Stein K.M., Markowitz S.M., et al. An update on electrical cardioversion of atrial fibrillation. Card Electrophysiol Rev 7 3 (2003) 285-289
27. Winkle R.A., Mead H., Ruder M.A., et al. Improved low energy defibrillation efficacy in man with the use of a biphasic truncated exponential waveform. Am Heart J 117 (1989) 122-127
28. Kroll M., Anderson K., Supino C., et al. Decline in defibrillation thresholds. Pacing Clin Electrophysiol 16 1 pt 2 (1993) 213-217
29. Bardy G.H., Marchlinski F.E., Sharma A.D., et al. Multicenter comparison of truncated biphasic shocks and standard damped sine wave monophasic shocks for transthoracic ventricular defibrillation. Transthoracic investigators. Circulation 94 10 (1996) 2507-2514
30. Ricard P., Levy S., Boccara G., et al. External cardioversion of atrial fibrillation: comparison of biphasic vs. monophasic waveform shocks. Europace 3 2 (2001) 96-99
31. Page R.L., Kerber R.E., Russell J.K., et al., BiCard Investigators. Biphasic versus monophasic shock waveform for conversion of atrial fibrillation: the results of an international randomized, double-blind multicenter trial. J Am Coll Cardiol 39 12 (2002) 1956-1963
32. Khaykin Y., Newman D., Kowalewski M., et al. Biphasic versus monophasic cardioversion in shock-resistant atrial fibrillation. J Cardiovasc Electrophysiol 14 8 (2003) 868-872
33. Botto G.L., Politi A., Bonini W., et al. External cardioversion of atrial fibrillation: role of paddle position on technical efficacy and energy requirements. Heart 82 (1999) 726-730
34. Brazdzionyte J., Babarskiene R.M., and Stanaitiene G. Anterior-posterior versus anterior-lateral electrode position for biphasic cardioversion of atrial fibrillation. Medicina (Kaunas) 42 12 (2006) 994-998
35. Kerber R.E., Jensen S.R., Grayzel J., et al. Elective cardioversion: influence of paddle-electrode location and size on success rates and energy requirements. N Engl J Med 305 (1981) 658-662
36. Ambler J.J., and Deakin C.D. A randomised controlled trial of the effect of biphasic or monophasic waveform on the incidence and severity of cutaneous burns following external direct current cardioversion. Resuscitation 71 3 (2006) 293-300
37. Levy S. Internal defibrillation: where we have been and where we should be going?. J Interv Card Electrophysiol 13 Suppl 1 (2005) 61-66
38. Timmermans C., Rodriguez L.M., Smeets J.L., et al. Immediate reinitiation of atrial fibrillation following internal atrial defibrillation. J Cardiovasc Electrophysiol 9 2 (1998) 122-128
39. Van Noord T., Van Gelder I.C., Schoonderwoerd B.A., et al. Immediate reinitiation of atrial fibrillation after electrical cardioversion predicts subsequent pharmacologic and electrical conversion to sinus rhythm and amiodarone. Am J Cardiol 86 12 (2000) 1384-1385 A5
40. Tieleman R.G., Van Gelder I.C., Crijns H.J., et al. Early recurrences of atrial fibrillation after electrical cardioversion: a result of fibrillation-induced electrical remodeling of the atria?. J Am Coll Cardiol 31 1 (1998) 167-173
41. Oral H., Ozaydin M., Sticherling C., et al. Effect of atrial fibrillation duration on probability of immediate recurrence after transthoracic cardioversion. J Cardiovasc Electrophysiol 14 2 (2003) 182-185
42. Chugh A., Ozaydin M., Scharf C., et al. Mechanism of immediate recurrences of atrial fibrillation after restoration of sinus rhythm. Pacing Clin Electrophysiol 27 1 (2004) 77-82
43. Husser D., Bollmann A., Kang S., et al. Determinants and prognostic significance of immediate atrial fibrillation recurrence following cardioversion in patients undergoing pulmonary vein isolation. Pacing Clin Electrophysiol 28 2 (2005) 119-125
44. Rossi M., and Lown B. The use of quinidine in cardioversion. Am J Cardiol 19 2 (1967) 234-238
45. Jacobs L.O., Andrews T.C., Pederson D.N., et al. Effect of intravenous procainamide on direct-current cardioversion of atrial fibrillation. Am J Cardiol 82 2 (1998) 241-242
46. Bianconi L., Mennuni M., Lukic V., et al. Effects of oral propafenone administration before electrical cardioversion of chronic atrial fibrillation: a placebo-controlled study. J Am Coll Cardiol 28 3 (1996) 700-706
47. De Simone A., Stabile G., Vitale D.F., et al. Pretreatment with verapamil in patients with persistent or chronic atrial fibrillation who underwent electrical cardioversion. J Am Coll Cardiol 34 3 (1999) 810-814
48. Tse H.F., Lau C.P., and Ayers G.M. Incidence and modes of onset of early reinitiation of atrial fibrillation after successful internal cardioversion, and its prevention by intravenous sotalol. Heart 82 3 (1999) 319-324
49. Sticherling C., Hsu W., Tada H., et al. Effects of verapamil and ibutilide on atrial fibrillation and postfibrillation atrial refractoriness. J Cardiovasc Electrophysiol 13 2 (2002) 151-157
50. Sticherling C., Ozaydin M., Tada H., et al. Comparison of verapamil and ibutilide for the suppression of immediate recurrences of atrial fibrillation after transthoracic cardioversion. J Cardiovasc Pharmacol Ther 7 3 (2002) 155-160
51. Daoud E.G., Hummel J.D., Augostini R., et al. Effect of verapamil on immediate recurrence of atrial fibrillation. J Cardiovasc Electrophysiol 11 11 (2000) 1231-1237
52. Frick M., Frykman V., Jensen-Urstad M., et al. Factors predicting success rate and recurrence of atrial fibrillation after first electrical cardioversion in patients with persistent atrial fibrillation. Clin Cardiol 24 3 (2001) 238-244
53. Kabukcu M., Demircioglu F., Yanik E., et al. Simultaneous double external DC shock technique for refractory atrial fibrillation in concomitant heart disease. Jpn Heart J 45 6 (2004) 929-936
54. Manios E.G., Mavrakis H.E., Kanoupakis E.M., et al. Effects of amiodarone and diltiazem on persistent atrial fibrillation conversion and recurrence rates: a randomized controlled study. Cardiovasc Drugs Ther 17 1 (2003) 31-39
55. Opolski G., Stanislawska J., Gorecki A., et al. Amiodarone in restoration and maintenance of sinus rhythm in patients with chronic atrial fibrillation after unsuccessful direct-current cardioversion. Clin Cardiol 20 4 (1997) 337-340
56. Oral H., Souza J.J., Michaud G.F., et al. Facilitating transthoracic cardioversion of atrial fibrillation with ibutilide pretreatment. N Engl J Med 340 24 (1999) 1849-1854
57. Ditchey R.V., and Karliner J.S. Safety of electrical cardioversion in patients without digitalis toxicity. Ann Intern Med 95 6 (1981) 676-679
58. Capucci A., Lenzi T., Boriani G., et al. Effectiveness of loading oral flecainide for converting recent-onset atrial fibrillation to sinus rhythm in patients without organic heart disease or with only systemic hypertension. Am J Cardiol 70 (1992) 69-72
59. Crijns H.J., van Wijk L.M., van Gilst W.H., et al. Acute conversion of atrial fibrillation to sinus rhythm: clinical efficacy of flecainide acetate. Comparison of two regimens. Eur Heart J 9 6 (1988) 634-638
60. Alboni P., Botto G.L., Baldi N., et al. Outpatient treatment of recent-onset atrial fibrillation with the "pill-in-the-pocket" approach. N Engl J Med 351 23 (2004) 2384-2391
61. Singh S., Zoble R.G., Yellen L., et al. Efficacy and safety of oral dofetilide in converting to and maintaining sinus rhythm in patients with chronic atrial fibrillation or atrial flutter the symptomatic atrial fibrillation investigative research on dofetilide (SAFIRE-D) study. Circulation 102 (2000) 2385-2390